19 Regarding macronutrient composition, there is a trend toward recommending a Mediterranean diet as it has the most scientific evidence to support it
Beneficial effect of pentadecapeptide BPC 157 on denervated muscle in rats
There are three GLP-1 FDA decisions expected in 2025, all for Novo Nordisks semaglutide: Ozempic for T2DM and peripheral artery disease (PAD) Wegovy SC for heart failure with preserved ejection fraction (HFpEF) and obesity The first oral GLP-1 ( oral formulation of Wegovy 25 mg ) for weight loss and weight loss plus secondary CV risk reduction Given the considerable continued growth expected in the GLP-1 pipeline, Prime Therapeutics talented team of clinical experts actively monitors this emerging landscape
For Canadian users specifically, I recommend establishing a relationship with a hormone optimization clinic before beginning any compound protocol
Carvalho-Tavares J, Hickey MJ, Hutchison J, Michaud J, Sutcliffe IT, Kubes P